Advertisement

Journal of Neurology

, Volume 260, Issue 1, pp 260–267 | Cite as

Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry

  • Susanna HornerEmail author
  • Kurt Niederkorn
  • Thomas Gattringer
  • Martin Furtner
  • Raffi Topakian
  • Wilfried Lang
  • Robert Maier
  • Andreas Gamillscheg
  • Franz Fazekas
Original Communication

Abstract

Paradoxical embolism due to a patent foramen ovale (PFO) is a possible cause of ischemic stroke, particularly in young cryptogenic stroke patients. In most cases, however, it is difficult to establish a firm etiological association and the debate about management is ongoing. The Austrian Paradoxical Cerebral Embolism Trial was designed as a prospective, national, multi-center, non-randomized registry to add further data on this topic before the completion of randomized controlled trials. Over 27 months 188 cryptogenic stroke/TIA patients ≤55 years were entered by 15 Austrian stroke units. Contrast transesophageal echocardiography demonstrated a cardiac right-to-left shunt (RLS) in 176 patients; a pulmonary RLS was assumed in 10, and 2 showed both. Ninety-seven (55 %) patients with cardiac RLS underwent interventional treatment, and this was more likely for patients with stroke as index event, a symptomatic infarction on MRI and a large size of PFO. Over 2 years, recurrences occurred at a rate of approximately 1.3 % for stroke and 4.3 % for TIA, and were especially frequent in patients with pulmonary RLS. When comparing outcomes in patients with cardiac RLS there was a trend for fewer recurrences with interventional management (closure: four TIA in four patients vs. medical: three strokes and seven TIA in nine patients; p = 0.066 for events, p = 0.085 for patients). The complication rate was 13.4, and 5.7 % had residual shunting. The possible causes for paradoxical embolism in young patients with cryptogenic stroke appear more variable than usually considered, and other causes than PFO should not be neglected. Interventional treatment of a cardiac RLS may offer a small benefit, but has to be weighed against possible complications and the problem of establishing causality.

Keywords

Paradoxical cerebral embolism Cryptogenic stroke Patent foramen ovale Right-to-left shunt Pulmonary arteriovenous malformation Transcatheter closure 

Notes

Acknowledgments

The study was financially supported by the Austrian Society of Stroke Research.

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standard

This study has been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

References

  1. 1.
    Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740–1746PubMedCrossRefGoogle Scholar
  2. 2.
    Overell JR, Bone I, Lees KR (2000) Intraatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172–1179PubMedCrossRefGoogle Scholar
  3. 3.
    Homma S, Sacco RL (2005) Patent foramen ovale and stroke. Circulation 112:1063–1072PubMedCrossRefGoogle Scholar
  4. 4.
    European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25(5):457–507 (Epub 6 May 2008)CrossRefGoogle Scholar
  5. 5.
    Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN (2011) American heart association stroke council, council on cardiovascular nursing, council on clinical cardiology, and interdisciplinary council on quality of care and outcomes research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 42(1):227–276PubMedCrossRefGoogle Scholar
  6. 6.
    Kenny D, Turner M, Martin R (2008) When to close a patent foramen ovale. Arch Dis Child 93(3):255–259PubMedCrossRefGoogle Scholar
  7. 7.
    Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM (2012) Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke 43(2):422–431 (Epub 15 Dec 2011)PubMedCrossRefGoogle Scholar
  8. 8.
    Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A (2012) Closure I investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366(11):991–999PubMedCrossRefGoogle Scholar
  9. 9.
    Kimura K, Minematsu K, Nakajima M (2004) Isolated pulmonary arteriovenous fistula without Rendu-Osler-Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatry 75(2):311–313PubMedGoogle Scholar
  10. 10.
    Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV (2006) American heart association; American stroke association stroke council. Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group. Circulation 113(24):e873–e923PubMedCrossRefGoogle Scholar
  11. 11.
    Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870PubMedCrossRefGoogle Scholar
  12. 12.
    Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604–607PubMedCrossRefGoogle Scholar
  13. 13.
    Gossage JR (2003) The role of echocardiography in screening for pulmonary arterivenous malformations. Chest 123:320–322PubMedCrossRefGoogle Scholar
  14. 14.
    Jauss M, Zanette E (2000) Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 10(6):490–496PubMedCrossRefGoogle Scholar
  15. 15.
    Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russel D, Siebler M (1998) Consensus on microembolus detection by TCD. International consensus group on microembolus detection. Stroke 29(3):725–729PubMedCrossRefGoogle Scholar
  16. 16.
    Meier B (2005) Closure of patent foramen ovale: technique, pitfalls, complications, and follow-up. Heart 91:444–448PubMedCrossRefGoogle Scholar
  17. 17.
    White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169:663–669PubMedGoogle Scholar
  18. 18.
    Gossage JR, Kanj G (1998) Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 158:643–661PubMedGoogle Scholar
  19. 19.
    Mono ML, Geister L, Galimanis A, Jung S, Praz F, Arnold M, Fischer U, Wolff S, Findling O, Windecker S, Wahl A, Meier B, Mattle HP, Nedeltchev K (2011) Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events. Stroke (Epub a head)Google Scholar
  20. 20.
    Mas JL, Zuber M (1995) Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am Heart J 130(5):1083–1088PubMedCrossRefGoogle Scholar
  21. 21.
    Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Lausanne stroke with paradoxal embolism study group. Neurology 46(5):1301–1305PubMedCrossRefGoogle Scholar
  22. 22.
    De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31(10):2407–2413PubMedCrossRefGoogle Scholar
  23. 23.
    Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A (2011) FORI (foramen ovale registro Italiano) investigators. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (foramen ovale registro Italiano) study. Cerebrovasc Dis 31(2):109–116PubMedCrossRefGoogle Scholar
  24. 24.
    Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP (2004) Carotid endarterectomy trialists collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363(9413):915–924PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Susanna Horner
    • 1
    Email author
  • Kurt Niederkorn
    • 1
  • Thomas Gattringer
    • 1
  • Martin Furtner
    • 2
  • Raffi Topakian
    • 3
  • Wilfried Lang
    • 4
  • Robert Maier
    • 5
  • Andreas Gamillscheg
    • 6
  • Franz Fazekas
    • 1
  1. 1.Department of NeurologyMedical University of GrazGrazAustria
  2. 2.Department of NeurologyMedical University of InnsbruckInnsbruckAustria
  3. 3.Department of NeurologyAcademic Teaching Hospital Wagner-JaureggLinzAustria
  4. 4.Department of NeurologyHospital Barmherzige BruederViennaAustria
  5. 5.Division of Cardiology, Department of Internal MedicineMedical University of GrazGrazAustria
  6. 6.Division of Paediatric Cardiology, Department of PaediatricsMedical University of GrazGrazAustria

Personalised recommendations